So many scenarios playing out in my mind...mostly centred on Resverlogix being a Nasdaq based company.  

Get on the Naz and I at least see the potential for Resverlogix to get some exposure to a broad base of Amercian investors and those who invest in US traded biotechs.  Fox Biz, CNBC, print and on-line media.....Epigentics is new and little understood, even by some of us (my hand is up) who are invested in it.  

A company that I follow but consider absolutely horrible is Vuzix, and they got a spot on Fox Bix....Ziopharm's Randall Kirk has appeared on CNBC.  

First we need that listing....then move over Amarin and make way for the Resverlogix train.....at least that's the dream scenario in my mind.  Bear's Door number 3 with good numbers on MACE, CKD and Cognition....where's my Uncle Bob?